Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Edwards Lifesciences, LLC
EIR
•Edwards Lifesciences, LLC•June 14, 2019

Edwards Lifesciences, LLC – FDA EIR, Jun 14, 2019

Record Details

An FDA "For Cause" inspection was conducted at Edwards Lifesciences, LLC in Irvine, CA, from May 28 to June 14, 2019. This inspection, conducted under C.P. 7382.845, followed four product recalls initiated by the company since December 2018, involving various cardiovascular medical devices like annuloplasty rings, catheters, and hemodynamic monitoring systems.

The inspection identified three main objectionable conditions, detailed in an FDA Form 483, Inspectional Observations. Firstly, procedures for corrective and preventive actions were not adequately established, notably failing to verify the effectiveness of prior corrective actions for liquid ingress issues causing power supply fires in EV1000 Clinical Platforms. Secondly, process control procedures lacked sufficient detail to ensure product conformance to specifications. Thirdly, procedures for receiving, reviewing, and evaluating customer complaints by a designated unit were not established, contributing to unescalated reports of device malfunctions.

Further discussions highlighted additional concerns: the EV1000 Clinical Platform's operator manual required clearer safety warnings for power supply mounting, risk analysis records for Swan-Ganz catheters contained conflicting information, and balloon inspection procedures needed clarification to prevent overwriting valid test results.

Dr. John P. McGrath, Corporate Vice President, Quality, Regulatory & Clinical, acknowledged the observations, committed to correcting all issues, and promised a written response to the FDA within 15 business days. The FDA also warned of potential sanctions for non-compliance.

Company
Edwards Lifesciences, LLC
Inspection date
June 14, 2019
Product type
devices
Office
Los Angeles District Office
Person
  • Janet Pulver (Investigator)
View Company Profile

ID · fa720c66-b9e9-43b8-9a9a-35e0d62b3f80

Violation Codes5
21 CFR 820.19821 CFR 820.3021 CFR 820.100(a)21 CFR 820.70(a)21 CFR 820.198(a)

Full citation text and observation details available on the Dashboard.

Other documents for Edwards Lifesciences, LLC
  • 483 - 2019-06-14June 14, 2019
  • WARNING_LETTER - 2013-02-22February 22, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Edwards Lifesciences, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.